Oncolytic H-1 Parvovirus Hijacks Galectin-1 to Enter Cancer Cells

Clinical studies in glioblastoma and pancreatic carcinoma patients strongly support the further development of H-1 protoparvovirus (H-1PV)-based anticancer therapies. The identification of cellular factors involved in the H-1PV life cycle may provide the knowledge to improve H-1PV anticancer potenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Tiago, Kulkarni, Amit, Bretscher, Clemens, Nazarov, Petr V., Hossain, Jubayer A., Ystaas, Lars A. R., Miletic, Hrvoje, Röth, Ralph, Niesler, Beate, Marchini, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146882/
https://www.ncbi.nlm.nih.gov/pubmed/35632759
http://dx.doi.org/10.3390/v14051018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146882/
https://www.ncbi.nlm.nih.gov/pubmed/35632759
http://dx.doi.org/10.3390/v14051018

Ejemplares similares